PNTG
The Pennant Group, Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$38.00
−1.40%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.1B | 947.7M | 695.2M | 544.9M | 473.2M |
| Cost of Revenue | 938.8M | 825.2M | 601.5M | 477.9M | 414.7M |
| Gross Profit | 162.9M | 122.5M | 93.8M | 67.0M | 58.6M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 94.6M | 71.1M | 50.2M | 36.7M | 34.0M |
| General & Admin Expense | 79.8M | 71.1M | 50.2M | 36.7M | 34.0M |
| Selling & Marketing Expense | 14.8M | — | — | — | — |
| Other Expenses | 4.8M | — | 5.4M | 5.2M | 11.9M |
| Total Operating Expenses | 99.3M | 71.1M | 55.6M | 41.9M | 45.8M |
| Cost and Expenses | 1.0B | 896.3M | 657.1M | 519.7M | 460.5M |
| Operating Income (EBIT) | 63.6M | 51.4M | 38.1M | 25.2M | 12.7M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 4.5M | 6.7M | 7.0M | 5.9M | 3.8M |
| Net Interest Income | (4.5M) | (6.7M) | (7.0M) | (5.9M) | (3.8M) |
| Other Non-Op Income/Expense | (11.0M) | (5.8M) | (6.7M) | (5.6M) | (3.8M) |
| Non-Operating Income (excl Interest) | 8.4M | (918.0K) | (207.0K) | (339.0K) | 31.0K |
| EBT (Pre-Tax Income) | 52.6M | 45.6M | 31.4M | 19.6M | 8.9M |
| Income Tax Expense | 14.1M | 11.9M | 7.0M | 5.7M | 1.6M |
| Bottom Line | |||||
| Net Income | 32.3M | 29.6M | 22.6M | 13.4M | 6.6M |
| Earnings from Cont. Ops | 38.5M | 33.8M | 24.3M | 13.9M | 7.2M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 32.3M | 29.6M | 22.6M | 13.4M | 6.6M |
| Per Share | |||||
| Basic EPS | $0.94 | $0.86 | $0.72 | $0.45 | $0.23 |
| Diluted EPS | $0.90 | $0.84 | $0.71 | $0.44 | $0.22 |
| Revenue Per Share | $31.63 | $27.42 | $22.29 | $18.25 | $16.28 |
| Shares | |||||
| Basic Shares Outstanding | 34.8M | 34.6M | 31.2M | 29.9M | 29.1M |
| Diluted Shares Outstanding | 36.0M | 35.3M | 32.0M | 30.2M | 30.2M |
| Profitability Metrics | |||||
| EBITDA | 65.3M | 60.8M | 44.4M | 30.6M | 17.6M |
| D&A | 10.2M | 8.5M | 6.1M | 5.1M | 4.9M |
| EBIT | 55.2M | 52.3M | 38.3M | 25.5M | 12.7M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026